Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

December 3, 2010

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

November 30, 2010

Everyone should boost intake of vitamin D, IOM says
The nation's top scientific advisory panel today recommended that adults modestly increase their intake of vitamin D, known as the "sunshine vitamin," from a daily dose of 200 international units to 600 international units. The panel also extended the safe upper limit for adults from 2000 IU to 4000 IU daily. The Institute of Medicine (IOM) report was released this morning in Washington, D.C., after two years of study and debate.
Read article at physorg.com
Comment: With a huge part of the American population now known to be deficient in vitamin D, and most people globally getting insufficient amounts, the decision of the U.S. Institute of Medicine to increase its recommended intake is undoubtedly a step in the right direction. However, it is important to understand that it is not the intake of any one single nutrient that ensures full health, but the intake of a complete spectrum of various different micronutrients, including vitamins, minerals, amino acids and trace elements. This is why the approach of Dr. Rath and Dr. Aleksandra Niedzwiecki at the Dr. Rath Research Institute concentrates upon the concept of nutrient synergy, a methodology which maximizes the health benefits of micronutrients because of the discovery they work best in "teams". The results of the studies carried out at the Dr. Rath Research Institute have repeatedly shown that utilizing a nutrient synergy-based approach is the most effective method of optimizing cellular metabolism and restoring its balance, and that this approach is significantly more effective than using either individual nutrients, or their random combination.

November 29, 2010

Magnesium reduces sudden heart failure risk for women: Harvard study
Increased intakes of magnesium-rich foods are associated with a reduced risk of sudden cardiac death, says new research from Brigham and Women's Hospital and Harvard Medical School. The highest dietary intakes of the mineral were associated with a 37 percent reduction in the risk of sudden cardiac death, compared with the lowest average intakes, according to new findings published in the American Journal of Clinical Nutrition. The apparent protective effects of magnesium were strongest when the researchers focused their attention on blood levels, with every 0.25 milligram per deciliter increase associated with a 41 percent reduction in the risk of sudden cardiac death.
Read article at nutraingredients-usa.org

November 25, 2010

Cinnamon’s anti-diabetes benefits get clinical trial boost
A daily dose of two grams of cinnamon for 12 weeks may improve blood pressure measures and blood sugar levels in people with type-2 diabetes, says new research from Imperial College London.
Read article at nutraingredients-usa.org

For more natural health news, click here.

See also our 2001-2009 news archive, by clicking here.

Pharma "Business with Disease" News

November 30, 2010

Tricyclic Antidepressants Associated With Increased Cardiovascular Risk
A large population-based study has shown a link between tricyclic antidepressant medications and an increased risk of cardiovascular disease, adding to a growing body of evidence that the medications carry cardiovascular risks – both for people with and without existing disease.
Read article on the Internal Medicine News website

November 24, 2010

Pfizer Loses Appeal of $58 Million Prempro Jury Award
Pfizer Inc. doesn’t deserve a new trial in a Nevada case over the company’s menopause drugs and must pay a $57.6 million jury award to three women who alleged the pills caused their cancers, the state’s highest court ruled. The Nevada Supreme Court concluded today that jurors properly held Pfizer’s Wyeth unit responsible for hiding the breast-cancer risks of its Premarin and Prempro menopause drugs.
Read article at Bloomberg.com

November 19, 2010

15 Dangerous Drugs Big Pharma Shoves Down Our Throats
In the pharmaceutical industry’s rush to get drugs to market, safety usually comes last. And the public suffers.
In the pharmaceutical industry’s rush to get drugs to market, safety usually comes last. Long studies to truly assess a drug's risks just delay profits after all -- and if problems do emerge after medication hits the market, settlements are usually less than profits. Remember, Vioxx still made money. The following drugs are so plagued with safety problems, it is a wonder they’re on the market at all. It's a testament to Big Pharma's greed and our poor regulatory processes that they are.
Read article at alternet.org

November 13, 2010

Medical Journals Complicit in Corruption of Medicine
A growing number of prominent physician-scientists, including several former journal editors, and New York Times columnists, have written sobering critiques about the corrupting impact pharmaceutical industry influence has had on medicine. That influence has debased the integrity of medical research, clinical practice and medicine's institutions.
Read article on the website of the Alliance for Human Research Protection (USA)

For more pharma "business with disease" news, click here.

See also our 2001-2009 news archive, by clicking here.

GMO News

November 11, 2010

GM mosquito wild release takes campaigners by surprise
Experts in the safety of genetically modified (GM) organisms have expressed concern over the release of GM mosquitoes into the wild on the Cayman Islands, which was publicised internationally only last month — a year after their initial release. The trial of the OX513A strain of the dengue-carrying Aedes aegypti mosquito, developed by UK biotechnology company Oxitec, was carried out on Grand Cayman island by the Cayman Islands' Mosquito Research and Control Unit (MRCU) in 2009, followed by a bigger release between May and October this year. Together they represent the first known release of GM mosquitoes anywhere in the world.
Read article at scidev.net

For more GMO news, click here.

See also our 2001-2009 news archive, by clicking here.

Other Health-related News

December 1, 2010

Experts dismiss vitamin D overdose concerns
The lack of vitamin D in the Australian population is a greater health risk than melanoma, an expert said following reports of concerns about excessive supplementation. Integrative medicine specialist and Mosman GP Mark Donohoe told Pharmacy eNews the “unexplained population-wide deficiency” in vitamin D was linked with increased risks of osteoporosis and cancers.
Read article at pharmacynews.com.au (Australia)

November 30, 2010

Study finds low vitamin D levels in northern California residents with metabolic syndrome
Researchers from the UC Davis Health System have found that compared with healthy controls, blood levels of vitamin D are significantly reduced in patients in the Sacramento area with metabolic syndrome, a constellation of disease risk factors that affects about one in three U.S. adults and predisposes them to diabetes, heart disease and stroke.
Read article at physorg.com

November 26, 2010

Low vitamin D levels linked to increased depression risk
The likelihood of having depression is significantly increased in people with deficient level of vitamin D, compared with people with adequate levels of the sunshine vitamin, says a new study. Data from the third US National Health and Nutrition Examination Survey revealed that people with vitamin D deficiency were at a 85 percent increased risk of having current depressive episodes, compared with people with sufficient levels, according to findings published in the International Archives of Medicine.
Read article at nutraingredients-usa.org

November 23, 2010

Action Alert: Natural, Bioavailable Forms of B6 in Peril!
Everyone says, “Take your vitamins.” If only they’d let us! Vitamin B6 is something of a miracle worker. The FDA bans one of the most bioavailable forms of it so a drug company can monopolize it. Now even the form of B-6 we can’t live without is at risk of being banned for the same reason—because a drug company wants it! Pyridoxamine—one of only three natural and bioavailable forms of B6—inhibits aging and disease progression. Unfortunately, FDA banned pyridoxamine in 2008 in response to a petition from a drug company that wanted to use it in their own drug formulation. An alternative to pyridoxamine, and one that has similar anti-glycation properties, is one of the other forms of vitamin B6—a compound called pyridoxal-5′-phosphate, or P5P. It’s the only one that can be used directly by the body without conversion. But now even P5P is under threat! The FDA has a petition from Medicure Pharma to ban P5P.
Read article on the website of the Alliance for Natural Health (USA)
Comment: Throughout the 20th century, the health benefits of vitamins and other natural health approaches have been strategically suppressed in the interest of the pharmaceutical investment business with patented drugs. In the United States, the Dietary Supplement Health and Education Act (DSHEA) of 1994 fundamentally changed this and triggered an explosion of science-based natural health research and evidence. This expansion of knowledge and awareness was so massive that it became a threat to the continuation of the pharmaceutical investment business. In this situation, the pharmaceutical lobby is now launching unprecedented attacks on DSHEA and demanding that natural, non-patentable nutrients are banned. To learn more about these attacks, click here. To read Medicure Pharma’s petition to the US FDA to ban pyridoxal-5′-phosphate (P5P), click here. If you live in the United States, click here to contact your Senators and Representatives and send an email demanding that they act to protect vitamin freedom and optimum health.

For more health-related news, click here.

See also our 2001-2009 news archive, by clicking here.

Political News

November 30, 2010

Brussels says first ever citizens' petition does not count
The entry into force of the EU's new citizens' initiative (ECI) - a petition procedure under the Lisbon Treaty allowing European citizens to demand action in a particular area - is likely to be welcomed by a legal battle between Greenpeace and the EU institutions. The environmental NGO has successfully collected the required 1 million signatories in a petition calling on the EU to ban GMOs, but officials from both the European Commission and the European Parliament say the move is premature. "We've always said that we take their opinion very seriously but it's not an ECI as the legislation is not yet in place," Michael Mann, the commission's administration spokesman, told this website on Tuesday (30 November). "Strictly speaking, they would have to do it all over again," he added. "The Greenpeace view that the petition counts as the Lisbon Treaty is in place doesn't stand up to legal scrutiny." A European Parliament official concurred. "We may end up going to court on this," the contact said.
Read article at euobserver.com
Comment: Unfortunately, it is anything but surprising that the Brussels EU is ignoring the voices of its citizens in connection with the so-called citizens’ initiative. Having previously called for curbs on citizen petitions, it is already abundantly clear that the real intention of the Brussels EU is to replace democracy with dictatorship. To learn more about this construct, and how it was designed as a dictatorship under the control of the Oil and Drug Cartel, click here.

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website. Citizens of the UK can find additional UK-orientated news stories on the Reject the EU website.


Back to the Newsletter Archive…